Skip to main content
. 2015 Jul 14;113(4):680–685. doi: 10.1038/bjc.2015.250

Table 2. Expression of phosphoproteins in all samples, RAS-mutated samples and RAS wild-type samples.

  All* RAS mutated* RAS wild type* P
pAKT 104.01; 98.5 (86.04; 124.55) 110.79; 109.46 (93.31; 126.27) 99.49; 92.83 (82.10; 122.07) 0.0246
pEGFR 139.35; 109.39 (86.69; 141.04) 174.69; 105.38 (88.58; 146.54) 115.80; 110.11 (85.16; 139.13) 0.9355
pERK1/2 245.73; 138.98 (101.59; 263.85) 350.22; 178.23 (137.87; 395.01) 176.07; 113.83 (92.04; 169.58) 0.0004
pGSK3 133.03; 101.05 (66.38; 183.82) 135.62; 97.79 (66.38; 168.41) 131.30; 105.88 (65.32; 184.71) 0.7676
pIGFR 83.65; 74.83 (64.29; 96.68) 83.52; 70.81 (63.89; 91.62) 83.74; 77.13 (64.70; 101.09) 0.4024
pMEK1 272.19; 131.82 (80.42; 280.74) 411.25; 209.52 (87.89; 402.14) 179.48; 104.09 (77.70; 201.28) 0.0110
pP70S6K 123.31; 112.49 (89.14; 135.21) 131.39; 124.47 (93.58; 136.83) 117.93; 105.24 (85.00; 135.21) 0.1690
pP90SRK 74.37; 75.61 (49.71; 95.38) 81.03; 80.27 (48.73; 101.78) 69.93; 71.78 (50.11; 88.26) 0.1303

Expression of pAKT, pERK1/2 and pMEK1 is significantly lower in RAS wild-type patients.

*Mean; median (lower quartile; upper quartile).